MAWAG
PASG icon

Mid-American Wealth Advisory Group’s Passage Bio PASG Stock Holding History

Mid-American Wealth Advisory Group’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2
Closed -$13 – 232
2025
Q2 		$13 Buy
+2
New +$15 ﹤0.01% 340

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mid-American Wealth Advisory Group's PASG Position: Q3 2025 in Review

Mid-American Wealth Advisory Group sold out of Passage Bio (PASG) in Q3 2025, closing a stake of 2 shares — an estimated $13 sold.

Mid-American Wealth Advisory Group first reported a position in PASG in Q2 2025 and held it in 1 quarter. The position peaked at $13 in Q2 2025. 32 funds tracked by Wall St. Rank hold PASG as of Q3 2025.

  • Mid-American Wealth Advisory Group reported no remaining Passage Bio position as of Q3 2025 after selling out during the quarter.
  • Mid-American Wealth Advisory Group sold 2 Passage Bio shares in Q3 2025, an estimated $13.
  • Mid-American Wealth Advisory Group first reported a position in Passage Bio in Q2 2025 and held it in 1 quarter.
  • Mid-American Wealth Advisory Group's Passage Bio position peaked at $13 in Q2 2025.
  • 32 funds tracked by Wall St. Rank held Passage Bio as of Q3 2025.

Based on Mid-American Wealth Advisory Group's 13F filing for Q3 2025, filed 20 Oct 2025.